AU2275700A - Sustained release composition comprising insuline like growth factor - Google Patents

Sustained release composition comprising insuline like growth factor

Info

Publication number
AU2275700A
AU2275700A AU22757/00A AU2275700A AU2275700A AU 2275700 A AU2275700 A AU 2275700A AU 22757/00 A AU22757/00 A AU 22757/00A AU 2275700 A AU2275700 A AU 2275700A AU 2275700 A AU2275700 A AU 2275700A
Authority
AU
Australia
Prior art keywords
insuline
growth factor
sustained release
release composition
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22757/00A
Inventor
Bruno Grander
Oscar E Illi
Lorenz Meinel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
White Spot AG
Original Assignee
White Spot AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by White Spot AG filed Critical White Spot AG
Publication of AU2275700A publication Critical patent/AU2275700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU22757/00A 2000-02-09 2000-02-09 Sustained release composition comprising insuline like growth factor Abandoned AU2275700A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CH2000/000074 WO2001058426A1 (en) 2000-02-09 2000-02-09 Sustained release composition comprising insuline like growth factor

Publications (1)

Publication Number Publication Date
AU2275700A true AU2275700A (en) 2001-08-20

Family

ID=4358040

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22757/00A Abandoned AU2275700A (en) 2000-02-09 2000-02-09 Sustained release composition comprising insuline like growth factor

Country Status (2)

Country Link
AU (1) AU2275700A (en)
WO (1) WO2001058426A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009005718A1 (en) * 2007-06-28 2009-01-08 Surmodics, Inc. Polypeptide microparticles having sustained release characteristics, methods and uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2653255B2 (en) * 1990-02-13 1997-09-17 武田薬品工業株式会社 Long-term sustained release microcapsules
US6573238B2 (en) * 1997-11-07 2003-06-03 Chiron Corporation Method for producing sustained-release formulations
WO2000000180A1 (en) * 1998-06-29 2000-01-06 White Spot Ag Utilization of growth factors for the production of medicaments

Also Published As

Publication number Publication date
WO2001058426A1 (en) 2001-08-16

Similar Documents

Publication Publication Date Title
AU2002246666A1 (en) Anti-icing composition
AU2001245660A1 (en) Embolic compositions
AU2001258801A1 (en) Gelling composition
AU2001266345A1 (en) Five-membered-ring compound
AU2001264264A1 (en) Sustained release compositions
AU2001233145A1 (en) Dispersant composition
AU2001274593A1 (en) Cold-setting composition
AU2001241098A1 (en) Composition
AU2001246861A1 (en) Sustained release preparations
AU2001248772A1 (en) Sustained release drug compositions
AU2001264109A1 (en) Parasiticidal composition
AU2002226047A1 (en) Release agent composition
AU2001275201A1 (en) Acne-treating composition
AU2001287852A1 (en) Composition
AUPR040900A0 (en) Mould release composition
AU2001235764A1 (en) Compositions
AU2002211741A1 (en) Surface modifying composition
AU2001267541A1 (en) Vaccine composition
AU2001287732A1 (en) Copolycarbonate-based composition
AU2275700A (en) Sustained release composition comprising insuline like growth factor
AU2001237378A1 (en) Herbicidal composition
AUPQ246999A0 (en) Insecticidal composition
AU2001262163A1 (en) Composition
AU2001252713A1 (en) Pesticide composition
AU2001244839A1 (en) Thermosetting composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase